Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Attached hereto and incorporated
herein is Qtrex Quantum Ltd.’s (the “Company”) Notice of Extraordinary General Meeting of Shareholders (the “Meeting”),
Proxy Statement and Proxy Card for the Meeting to be held on December 28, 2026.
Only shareholders of record
who hold ordinary shares, no par value, of the Company at the close of business on November 25, 2026, will be entitled to notice of and
to vote at the Meeting and any postponements or adjournments thereof.
This Foreign Private Issuer
Report on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-284308,
333-289324 and 333-296482) and Form S-8 (Registration Nos. 333-297590, 333-259057, 333-277980, 333-285565, 333-290162 and 333-292592), filed
with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
Exhibit 99.1
QTREX QUANTUM
LTD.
NOTICE OF EXTRAORDINARY
GENERAL MEETING OF SHAREHOLDERS
Notice is hereby given
that an Extraordinary General Meeting of Shareholders (the “Meeting”) of QTREX Quantum Ltd.
(“QTREX” or the “Company”) will be held on December 28, 2026, at 2:00
p.m. Israel time at the Company’s office, located at 2 Ilan Ramon St., Ness-Ziona, 7403635, Israel.
The Meeting is being
called for the following purposes:
| 1. | To
approve the issuance of the Company’s ordinary shares underlying the Penny Warrants and the Additional
Warrants, upon exercise thereof, each as defined in the accompanying proxy statement, exercisable to purchase
the Company’s ordinary shares, no par value per share, as part of the consideration of the Share and
Intercompany Debt Purchase Agreement between the Company and Nano Dimension Ltd., dated as of November 16,
2026, to acquire all of the issued and outstanding shares and intercompany debt of Global Inkjet Systems
Limited (“Proposal 1”); |
Board
Recommendation
The Board unanimously
recommends that you vote in favor of Proposal 1, as described in the accompanying proxy statement (the
“Proxy Statement”).
Record
Date
Shareholders of record at
the close of business on November 25, 2026 (the “Record Date”), are entitled to notice of
and to vote at the Meeting, either in person or by appointing a proxy to vote in their stead at the Meeting
(as detailed below).
Required Vote and
Voting Procedures
Pursuant to the Israeli
Companies Law, 5759-1999 (the “Companies Law”), Proposal 1, as described below, requires
the affirmative vote of shareholders present at the Meeting, in person or by proxy, and holding Ordinary
Shares representing, in the aggregate, at least a majority of the votes cast by shareholders at the Meeting
with respect to Proposal 1 (a “Simple Majority”).
How You Can
Vote
A form of proxy for use at
the Meeting is attached to the Proxy Statement, and together with a return envelope, will be sent to holders
of the Company’s Ordinary Shares. By appointing “proxies,” shareholders may vote at the
Meeting regardless of whether they attend in person. If a properly executed proxy in the attached form is
received by the Company at least four (4) hours prior to the Meeting, all of the Ordinary Shares represented
by the proxy shall be voted as indicated on the form. Subject to applicable law and the rules of the Nasdaq
Stock Market, in the absence of instructions, the Ordinary Shares represented by properly executed and
received proxies will be voted “FOR” Proposal 1, for which the Board recommends a vote
“FOR”.
Shareholders may revoke
their proxies or voting instruction form (as applicable) in accordance with Section 9 of the Companies Law
regulations (proxy and position statements), by filing with the Company a written notice of revocation or duly
executed proxy or voting instruction form (as applicable) bearing a later date and time.
Shareholders of
Record
If your shares are
registered directly in your name with our transfer agent, Equinity Trust Company LLC, you are considered, with
respect to those shares, the shareholder of record. In such case, these proxy materials are being sent
directly to you. As the shareholder of record, you have the right to use the proxy card included with this
Proxy Statement to grant your voting proxy directly to Yafit Tehila, the Chief Financial Officer of the
Company (yafit@q-trex.com), or to vote in person at the Meeting.
Beneficial
Owners
If your shares are held
through a bank, broker or other nominee, they are considered to be held in “street name” and you
are the beneficial owner with respect to those shares. A beneficial owner as of the Record Date has the right
to direct the bank, broker or nominee how to vote the shares held by such beneficial owner at the Meeting. If
your shares are held in “street name,” as of the Record Date, these proxy materials will be
forwarded to you by your bank, broker or nominee who is considered, with respect to those shares, as the
shareholder of record, together with a voting instruction card for you to use in directing the bank, broker or
nominee how to vote your shares. You also may attend the Meeting. Since a beneficial owner is not a
shareholder of record, you may not vote those shares directly at the Meeting unless you obtain a “legal
proxy” from the bank, broker or other nominee that holds your shares directly, giving you the right to
vote the shares at the Meeting. Abstentions and “broker non-votes” are counted as present and entitled to vote for purposes of determining a quorum. A
“broker non-vote” occurs when a bank, broker or other holder of record holding Ordinary Shares for a beneficial owner attends
the Meeting but does not vote on a particular Proposal because that holder does not have discretionary voting power for that particular
item and has not received instructions from the beneficial owner. Brokers that hold Ordinary Shares of the Company in “street name” for clients (as described above) typically have authority to vote on “routine” Proposals even when they have not received instructions from beneficial owners. Proposal 1 is the only item on the Meeting
agenda, and we believe it is non-routine; however, we cannot be certain whether it will be treated as a routine matter since our Proxy Statement is prepared in compliance with the Companies Law, rather than the rules applicable to domestic U.S. reporting companies. Therefore, it is important for a shareholder
that holds Ordinary Shares of the Company through a bank or broker to instruct its bank or broker how to vote its Ordinary Shares, if
the shareholder wants its Ordinary Shares of the Company to count for Proposal 1.
| | Sincerely, |
| | |
| | /s/
Tal Parnes |
| | Chairman of the Board of
Directors |
| | |
| | November 20, 2026 |
QTREX QUANTUM
LTD.
NESS-ZIONA,
ISRAEL
PROXY STATEMENT
EXTRAORDINARY GENERAL
MEETING OF SHAREHOLDERS
TO BE HELD ON DECEMBER 28,
2026
The enclosed proxy
statement (the “Proxy Statement”) is being solicited by the board of directors (the
“Board of Directors”) of QTREX Quantum Ltd. (the “Company”) for use at
the Company’s extraordinary general meeting of shareholders (the “Meeting”) to be
held on December 28, 2026, at 2:00 p.m. Israel time, or at any adjournment or postponement thereof.
Upon the receipt of a
properly executed proxy in the form enclosed, the persons named as proxies therein shall vote the ordinary
shares, no par value, of the Company (the “Ordinary Shares”) covered thereby in accordance
with the directions of the shareholders executing the proxy. In the absence of such directions, and except as
otherwise mentioned in this Proxy Statement, the Ordinary Shares represented thereby shall be voted in favor
of Proposal 1.
Quorum
Two or more shareholders
present, personally or by proxy, holding in the aggregate not less than twenty-five percent (25%) of the
Company’s outstanding Ordinary Shares, shall constitute a quorum for the Meeting. If within half an hour
from the time the Meeting is convened a quorum is not present, the Meeting shall stand adjourned until
December 28, 2026, at 3:00 p.m. Israel time (the “Adjourned Meeting”). At the Adjourned
Meeting, any number of shareholders present personally or by proxy shall be deemed a quorum and shall be
entitled to deliberate and to resolve in respect of the matters for which the Meeting was convened.
Abstentions and “broker non-votes” are counted as present and entitled to vote for purposes of determining a
quorum (see “Beneficial Owners” in the Notice for a description of broker non-votes).
Required Majority
Pursuant to the Israeli
Companies Law, 5759-1999 (the “Companies Law”), Proposal 1, as described below, requires
the affirmative vote of shareholders present at the Meeting, in person or by proxy, and holding Ordinary
Shares representing, in the aggregate, at least a majority of the votes cast by shareholders at the Meeting
with respect to Proposal 1 (a “Simple Majority”).
In accordance with the
Companies Law and the regulations promulgated thereunder, any shareholder of the Company holding at least 1%
of the Company's outstanding voting rights for the Meeting may submit to the Company a proposed additional
agenda item for the Meeting (and in case of a proposed additional agenda item for nomination or removal of a
director, at least five percent (5%)) to Ms. Yafit Tehila, via e-mail (yafit@q-trex.com) no later than
November 27, 2026. All such submissions must comply with the requirements under the Companies Law, the
regulations promulgated thereunder, and the Current Articles.
Position Statements
Shareholders wishing to
express their position on an agenda item for this Meeting may do so by submitting a written statement (a
“Position Statement”) to the Company’s offices at 2 Ilan Ramon St., Ness-Ziona,
7403635, Israel. Any Position Statement received shall be furnished with the U.S. Securities and Exchange
Commission (“SEC”) on a Report of Foreign Private Issuer on Form 6-K and be made available
to the public on the SEC’s website at www.sec.gov. Position Statements should be submitted to the
Company no later than December 14, 2026. A shareholder is entitled to contact the Company directly and receive
the text of the proxy card and any Position Statement. The Board of Directors’ response to the Position
Statement shall be submitted no later than December 19, 2026.
It is noted that there may
be changes on the agenda after publishing the Proxy Statement, including Position Statements. Therefore, the
most updated agenda shall be furnished with the SEC on a Report of Foreign Private Issuer on Form 6-K and
shall be made available to the public on the SEC’s website at www.sec.gov.
PROPOSAL 1
TO APPROVE THE ISSUANCE
OF THE COMPANY’S ORDINARY SHARES UNDERLYING THE PENNY WARRANTS AND ADDITIONAL WARRANTS, AS DEFINED IN THE
ACCOMPANYING PROXY STATEMENT, UPON EXERCISE THEREOF, AS PART OF THE CONSIDERATION OF THE SHARE AND INTERCOMPANY
DEBT PURCHASE AGREEMENT BETWEEN THE COMPANY AND NANO DIMENSION LTD., TO ACQUIRE ALL OF THE ISSUED AND
OUTSTANDING SHARES OF GLOBAL INKJET SYSTEMS LIMITED
Background
Under Nasdaq Listing Rule
5635(d), shareholder approval is required before the issuance of securities in a private placement if the
transaction involves the sale, issuance or potential issuance of common stock or securities convertible into
or exercisable for common stock equal to 20% or more of the common stock or voting power outstanding before
the issuance, at a price below the minimum price, as defined in the Nasdaq rules.
The Acquisition
and the Consideration Securities
On November 16, 2026 (the
“Issue Date” and “Closing Date”), the Company entered into and
consummated the share and intercompany debt purchase agreement (the “Agreement”) with Nano
Dimension Ltd. (“Nano”), pursuant to which the Company acquired all of the issued and
outstanding shares of Global Inkjet Systems Limited (“GIS”) and the rights to the
transaction intercompany debt and any other intercompany debt transferred under the Agreement (collectively,
the “Acquisition”).
The consideration paid by the Company for the
Acquisition entirely in securities of the Company and subject to the adjustments set forth in the Agreement. The securities issued
or issuable in connection with the Acquisition include: (i) 3,551,693 Ordinary Shares; (ii) pre-funded warrants exercisable to
purchase up to 10,130,977 Ordinary Shares with an exercise price of $0.0001 per Ordinary Share (the “Pre-Funded
Warrants”); (iii) a separate holdback pre-funded warrant exercisable to purchase up to 545,455 Ordinary Shares with an
exercise price of $0.0001 per Ordinary Share; (iv) penny warrants exercisable to purchase up to 317,329 Ordinary Shares with an
exercise price of $0.0001 per Ordinary Share (the “Penny Warrants”); and (v) additional warrants exercisable to
purchase up to 10,909,091 Ordinary Shares with an exercise price of $1.21 per Ordinary Share (the “Additional
Warrants” and together with the Penny Warrants, the “Warrants”). The base consideration, which does not
include the Additional Warrants, was valued at US$16 million, based on a price of $1.10 per Ordinary Share, subject to
adjustment.
The Company is seeking
shareholder approval for the issuance of the Warrants, which reflect part of the consideration for the
Acquisition.
Proposed Terms of the
Penny Warrants and Additional Warrants
On the Closing Date, the
Company issued Penny Warrants that are exercisable to purchase up to 317,329 Ordinary Shares, subject to the
receipt of shareholder approval. Its aggregate exercise price was prepaid, except for a remaining nominal
exercise price of $0.0001 per Ordinary Share, and it may be exercised on a cashless basis. If shareholder
approval for the exercise of the Penny Warrants is not obtained by the 90th day following the issuance date of
the Penny Warrants (the “End Date”), Nano may, in its sole discretion, require (the
“Redemption Notice”, and “Redemption Option”, respectively) the Company
to redeem the Penny Warrant in its entirety for $349,061.90 in cash, payable within three trading days after
the Company receives a Redemption Notice.
In addition, on the
Closing Date, the Company issued the Additional Warrants that are exercisable to purchase up to 10,909,091
Ordinary Share, at an exercise price of $1.21 per Ordinary Share, subject to the receipt of shareholder
approval. The Additional Warrants expire on the earliest of (i) the closing of the Redemption Option, (ii) the
second anniversary of the date Shareholder Approval is obtained, and (iii) the second anniversary of the End
Date. If Shareholder Approval is not obtained by the End Date, Nano may, in its sole discretion, require the
Company to redeem the entirety of the Additional Warrants for $1,000,000 in cash, payable within three trading
days after the Company receives Nano’s Redemption Notice.
The Agreement also
requires the Company to use its best efforts to file a resale registration statement within 21 days after
Closing Date.
The Warrants also provide
for adjustments to the exercise price and/or the number of Ordinary Shares underlying the Warrants in
connection with share dividends, share splits, rights offerings, distributions, reorganizations and similar
events.
Pursuant to the Agreement,
the Company is required to hold a shareholders’ meeting to seek shareholder approval for the issuance of
Ordinary Shares underlying the Penny Warrants and the Additional Warrants upon exercise thereof, as promptly
as practicable after the Closing Date and, in any event, no later than 45 days after Closing. If the required
shareholder approval is not obtained at that meeting, the Company is required to hold another
shareholders’ meeting no later than 90 days after the date of the Agreement and, in connection with that
meeting, to engage a proxy solicitor. If the required shareholder approval is not obtained by that deadline,
the Company is required to continue holding shareholders’ meetings every 45 days thereafter until the
required shareholder approval is obtained or the Penny Warrants and the Additional Warrants are
terminated.
Board’s
Recommendation
The Board believes that
the Acquisition of GIS brings key production controls in-house and expands the Company’s capacity to
manufacture cryogenic interconnects at commercial scale. GIS’s hardware, software and fluid-delivery
systems support the materials-deposition process used in the Company’s additively manufactured
electronics production. The Board expects that the Company will use GIS’s capabilities to increase
production throughput, improve consistency in the radio-frequency performance of its cryogenic interconnects,
and develop additional interconnect materials and embedded passive components. The Board also believes that
the Acquisition will support the Company’s anticipated commercial opportunities in quantum computing.
GIS is expected to continue operating from its Cambridge facility, where its engineering team develops
products and supports existing customers.
In making its decision to
approve the issuance of Penny Warrants and Additional Warrants as part of the consideration of the
Acquisition, and recommend that the Company’s shareholders approve the same, the Board considered, among
other things: (i) the strategic fit between GIS’s printhead control, software and fluid-delivery
capabilities and the Company’s plans to scale production of cryogenic interconnects; (ii) the
opportunity to bring key production capabilities, an experienced engineering team, technology and intellectual
property in-house; (iii) the potential to accelerate the development of larger, multi-head production systems,
increase production throughput and improve consistency in the performance of the Company’s
products; (iv) the opportunity to develop additional interconnect materials and support the Company’s
anticipated commercial opportunities in quantum computing; and (v) the time, cost and execution risks of
developing comparable capabilities internally. The Board also considered the Company’s review of
GIS’s business, operations and financial forecasts, and the valuation analysis presented to it. Based on
these considerations, the Board determined that the Transaction is in the best interests of the Company and
its shareholders and recommends that the shareholders approve the proposed issuance.
The shareholders of the
Company are requested to adopt the following resolution:
“RESOLVED, to
approve the issuance of the Company’s Ordinary Shares underlying the Penny Warrants and the Additional
Warrants, upon exercise thereof, as part of the consideration of the Agreement between the Company and Nano,
to acquire all of the issued and outstanding shares of GIS, as set forth in the Proxy
Statement.”
The approval of Proposal 1
requires the affirmative vote of a Simple Majority, as defined in this Proxy Statement.
The Board of Directors unanimously recommends
a vote FOR the above proposal.
Your vote is important!
Shareholders are urged to complete and return their proxies promptly in order to, among other things,
ensure action by a quorum and to avoid the expense of additional solicitation. If the accompanying proxy is
properly executed and returned in time for voting, and a choice is specified, the shares represented thereby
shall be voted as indicated thereon. EXCEPT AS MENTIONED OTHERWISE IN THIS PROXY STATEMENT, IF NO
SPECIFICATION IS MADE, THE PROXY SHALL BE VOTED IN FAVOR OF EACH OF THE PROPOSALS DESCRIBED IN THIS PROXY
STATEMENT.
Proxies and all other applicable materials
should be sent to:
Equinity Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
ADDITIONAL
INFORMATION
The Company is subject to
the informational requirements of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange
Act”), as applicable to foreign private issuers. Accordingly, the Company files reports and other
information with the SEC. All documents which the Company will file on the SEC’s EDGAR system will be
available for retrieval on the SEC’s website at http://www.sec.gov.
As a foreign private
issuer, the Company is exempt from the rules under the Exchange Act prescribing certain disclosure and
procedural requirements for proxy solicitations. In addition, the Company is not required under the Exchange
Act to file periodic reports and financial statements with the SEC as frequently or as promptly as United
States companies whose securities are registered under the Exchange Act. The Notice of the Extraordinary
General Meeting of Shareholders and the proxy statement have been prepared in accordance with applicable
disclosure requirements in the State of Israel.
YOU SHOULD RELY ONLY ON
THE INFORMATION CONTAINED IN THIS PROXY STATEMENT OR THE INFORMATION FURNISHED TO YOU IN CONNECTION WITH THIS
PROXY STATEMENT WHEN VOTING ON THE MATTERS SUBMITTED TO SHAREHOLDER APPROVAL HEREUNDER. THE COMPANY HAS NOT
AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS DOCUMENT.
THIS PROXY STATEMENT IS DATED NOVEMBER 20, 2026. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS
DOCUMENT IS ACCURATE AS OF ANY DATE OTHER THAN NOVEMBER 20, 2026, AND THE MAILING OF THIS DOCUMENT TO
SHAREHOLDERS SHOULD NOT CREATE ANY IMPLICATION TO THE CONTRARY.
| | By Order of the Board of Directors |
| | QTREX Quantum Ltd. |
| | |
| | /s/
Tal Parnes |
| | Chairman of the Board of Directors |
| | |
| | November 20, 2026 |
* * *
QTREX QUANTUM
LTD.
PROXY
THIS PROXY IS SOLICITED
ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby
appoints, Yafit Tehila, Chief Financial Officer of QTREX Quantum Ltd. (the “Company”) and
Dagi Ben-Noon, Chief Executive Officer of the Company, and each of them, agents and proxies of the
undersigned, with full power of substitution to each of them, to represent and to vote on behalf of the
undersigned all the Ordinary Shares of the Company which the undersigned is entitled to vote at the
Extraordinary General Meeting of Shareholders (the “Meeting”) to be held on December 28,
2026 at 2:00 p.m. Israel time, and at any adjournments or postponements thereof, upon the following matters,
which are more fully described in the Notice of Extraordinary General Meeting of Shareholders and proxy
statement relating to the Meeting.
This Proxy, when properly
executed, shall be voted in the manner directed herein by the undersigned. If no direction is made with
respect to any matter, this Proxy shall be voted FOR such matter. Any and all proxies heretofore given by the
undersigned are hereby revoked.
(Continued and to be
signed on the reverse side)
QTREX QUANTUM
LTD.
EXTRAORDINARY GENERAL
MEETING OF SHAREHOLDERS
Date of Meeting: December
28, 2026
PLEASE SIGN, DATE AND
RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE
MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE
☒
| 1. | To
approve the issuance of the Company’s Ordinary Shares underlying the Penny Warrants and the Additional
Warrants, upon exercise thereof, as part of the consideration of the Agreement between the Company and Nano,
to acquire all of the issued and outstanding shares of GIS, as set forth in the Proxy
Statement. |
In their discretion, the proxies are authorized to
vote upon such other matters as may properly come before the Meeting or any adjournment or postponement thereof.
| | | | | |
| NAME | | SIGNATURE | | DATE |
| | | | | |
| | | | | |
| NAME | | SIGNATURE | | DATE |
Please sign exactly as
your name appears on this Proxy. When shares are held jointly, each holder should sign. When signing as
executor, administrator, trustee or guardian, please give full title as such. If the signed is a corporation,
please sign full corporate name by duly authorized officer, giving full title as such. If signer is a
partnership, please sign in partnership name by authorized person.